![Hugo Vanderstichele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hugo Vanderstichele
Plus aucun poste en cours
Profil
Hugo Vanderstichele is the founder and has worked as a Director of Assay Development at ADx NeuroSciences NV, which he founded in 2011.
He received his undergraduate degree from Ghent University.
Anciens postes connus de Hugo Vanderstichele
Sociétés | Poste | Fin |
---|---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Fondateur | - |
Formation de Hugo Vanderstichele
Ghent University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |